3′,5′-cyclic phosphoramidate prodrugs for HCV infection
US9109001B2 · kind B2 · utility
44Cited by
135References
28Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 21, 2013 |
| Grant date | Aug 18, 2015 |
| Priority date | — |
| Expiry date | May 21, 2033 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07H19/11
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Provided herein are compounds, compositions and methods for the treatment of Flaviviridae infections, including HCV infections. In certain embodiments, compounds and compositions of nucleoside derivatives are disclosed, which can be administered either alone or in combination with other anti-viral agents.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.